Pharmacologic inhibition of preterm labor

American Journal of Obstetrics and Gynecology

Volumn 133, Issue 5, 1979, Pages 557-578

  Caritis, Steve N ^a   Edelstone, Daniel I ^a   Mueller Heubach, Eberhard ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; DIAZOXIDE; FENOTEROL; INDOMETACIN; ISOXSUPRINE; MAGNESIUM SULFATE; MECLOFENAMIC ACID; MEDROXYPROGESTERONE ACETATE; NAPROXEN; ORCIPRENALINE; PHENYLBUTAZONE; PLACEBO; PROGESTERONE; PROSTAGLANDIN INHIBITOR; RITODRINE; SALBUTAMOL; TERBUTALINE;

DRUG THERAPY; MAJOR CLINICAL STUDY; PERINATAL MORBIDITY; PREGNANCY; PREMATURE LABOR; PREMATURITY; SHORT SURVEY; THERAPY; TOCOLYSIS;

ADRENERGIC BETA-AGONISTS; DIAZOXIDE; ETHANOL; FEMALE; HUMAN; INFANT, NEWBORN; ISOXSUPRINE; LABOR, PREMATURE; MAGNESIUM SULFATE; PREGNANCY; PROGESTERONE; PROSTAGLANDIN ANTAGONISTS; RITODRINE; TERBUTALINE;

EID: 0018342262     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(79)90292-8     Document Type: Article

References (216)

1. Annual summary of vital statistics—1974
2. Outlook for the low birthweight baby—then and now
3. Premature baby statistics
4. Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery
5. Recent improvement in outcome for the small premature infant. Follow-up of infants with a birth weight of less than 1,500 grams
6. Determinants of the neonatal mortality
7. Neurological sequelae in children surviving mechanical ventilation in the neonatal period
8. Early growth and development in low-birthweight infants following treatment in an intensive care nursery
9. Birth weight, gestational age, and neonatal risk
10. Premature labor and the small-for-dates infant
11. Premature labour
12. Neonatal respiratory distress following elective delivery. A preventable disease?
13. Hyperthyroidism and pregnancy
14. Hyperparathyroidism during pregnancy
15. Cushing's syndrome and pregnancy
16. Orgasm during late pregnancy. Possible deleterious effects
17. Orgasm and premature labour
18. Maternal, fetal and environmental factors in prematurity
19. Pathogenesis and prognosis of prematurity
20. Factors associated with spontaneous pre-term birth
21. Mycoplasmas and human reproductive failure
22. Contribution of preterm delivery to perinatal mortality
23. Twin pregnancy
24. Congenital abnormalities of the uterus and foetal wastage
25. Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device
26. Complications of pregnancy with an intrauterine contraceptive device in situ
27. Effect of legal termination on subsequent pregnancy
28. Second-trimester abortion after vaginal termination of pregnancy
29. Comparative morbidity after vaginal termination with regard to parity and gestational age
30. Induced abortion and subsequent outcome of pregnancy in a series of American women
31. Premature labor: Its management and therapy
32. A clinical approach to the therapy of premature labor
33. Sympathomimetic drugs to inhibit preterm labor
34. Management of premature labor
35. Therapeutic approaches to premature labor
36. Prevention of prematurity
37. Intravenous alcohol—a single blind study in the prevention of premature delivery: A preliminary report
38. Effect of alcohol on threatened premature labor
39. The pharmacologic control of excessive uterine activity with isoxsuprine
40. Results of double-blind, multicentre study with ritodrine in premature labour
41. Intravenous infusion of salbutamol in the management of premature labour
42. Effect of terbutaline on premature labor
43. A controlled study of ethanol in threatened premature labor
44. Treatment of imminent premature labour
45. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
46. Previous reproductive history in mothers presenting with spontaneous abortion
47. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants
48. Intrauterine transfusion
49. Oxytocin and the onset of labour in rabbits
50. Effect of alcohol on release of oxytocin
51. The inhibitory effect of ethanol on the release of oxytocin during parturition in the rabbit
52. Ethanol and the inhibition of oxytocin release in lactating rats
53. Oxytocin-equivalent activity in the plasma of women in labor and during the puerperium
54. Effect of ethanol on uterine activity during suckling in post-partum women
55. The development of a radioimmunoassay for oxytocin: The extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood
56. Release of oxytocin and vasopressin by the human foetus during labour
57. Oxytocin in maternal and fetal blood
58. Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration
59. Oxytocin levels in mother and fetus during parturition
60. The effect of ethanol on the myometrial response to oxytocin in women at term
61. Possible mechanisms of the inhibition of labor by ethanol
62. Effect of intravenous alcohol on premature labour
63. Behandlung von drohender Frühgeburt mit Alkoholinfusion
64. Failure to prevent premature labor with ethanol
65. A comparison of magnesium sulfate and alcohol for the prevention of premature labor
66. Inhibition of premature labor: A multicenter comparison of ritodrine and ethanol
67. The aliphatic alcohols
68. Metabolic and hepatic effects of alcohol
69. Lactic acidosis
70. Severe lactic acidosis associated with intravenous alcohol for premature labor
71. Elimination and metabolic effects of ethanol in mother, fetus, and newborn infant
72. Ethanol elimination in a mother and her premature twins
73. Acute transplacental ethanol intoxication
74. Acute effects of maternal ethanol infusion on fetal cardiac performance
75. Effect of alcohol on fetal cerebral function and metabolism
76. Placental transport of alcohol and its effect on maternal and fetal acid-base balance
77. Effect of ethanol on maternal and fetal acid-base balance
78. Effect of ethanol on uterine and umbilical hemodynamics and oxygen transfer
79. Effect of ethanol upon uterine activity and fetal acid-base state of the rhesus monkey
80. The function of prostaglandins in reproduction
81. Prostaglandins in human reproduction
82. Initiation of human parturition
83. Maternal and fetal plasma prostaglandin levels at vaginal delivery and cesarean section
84. F prostaglandins in amniotic fluid during pregnancy and labour
85. 2α concentrations in peripheral blood during the first stage of normal labour
86. Prostaglandin antagonists
87. Substances that inhibit the actions of prostaglandins
88. Drugs which inhibit prostaglandin biosynthesis
89. Regulation of the arachidonic acid cascade
90. polypeptides—Angiotensin, plasma kinins, and other vasoactive agents; prostaglandins
91. Aspirin selectively inhibits prostaglandin production in human platelets
92. Prostaglandin production contributes to the contractions of the rat isolated uterus
93. Aspirin and indomethacin prolong parturition in rats: Evidence that prostaglandins contribute to expulsion of foetus
94. The delay of spontaneous labor by naproxen in the rat model
95. Indomethacin block of normal onset of parturition in primates
96. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour
97. Aspirin and indomethacin: Effect on instillation/abortion time of mid-trimester hypertonic saline induced abortion
98. The influence of aspirin on the course of induced midtrimester abortion
99. Inhibition of labor by prostaglandin antagonists in impending abortion and preterm and term labour
100. Inhibition of human premature labor by indomethacin
101. The effect of indomethacin in labour at term
102. Premature labor and indomethacin
103. Analgesic-antipyretic-anti-inflammatory agents and drugs employed in the therapy of gout
104. Maternal effects of regular salicylate ingestion in pregnancy
105. Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis
106. Non steroid anti-inflammatory drugs and pregnancy
107. Perinatal use of indomethacin
108. Inhibition of prostaglandin synthesis and the response of baboon cerebral circulation to carbon dioxide
109. Action of salicylate on prenatal development
110. The possible teratogenic effect of salicylates on the developing fetus
111. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus
112. Congenital malformations and environmental influences in pregnancy
113. Fetal effects of regular salicylate ingestion in pregnancy
114. Perinatal mortality and birthweight in relation to aspirin taken during pregnancy
115. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis
116. The effects of antenatal drug administration on aggregation of platelets of newborn infants
117. Hemorrhage in a neonate possibly due to maternal ingestion of salicylate
118. 2α on umbilical blood flow and fetal hemodynamics
119. The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro
120. Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor
121. Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits
122. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero
123. The effects of indomethacin on the pulmonary vascular response to hypoxia in the premature and mature newborn goat (39108)
124. Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction
125. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn
126. Calcium and uterine smooth muscle membrane potentials
127. 89 movements with contraction of depolarized smooth muscle
128. Effect of toxemia therapy on uterine dynamics
129. In vitro and in vivo effects of magnesium sulfate on human uterine contractility
130. The effects of magnesium therapy on the duration of labor
131. Effects of magnesium sulfate on uterine contractility, intrauterine fetus, and infant
132. Magnesium metabolism
133. Failure to anesthetize human subjects by intravenous administration of magnesium sulfate
134. Hypermagnesemia in the newborn infant
135. Effect of maternally administered magnesium sulfate on the neonate
136. The clinical and biochemical effects of excess magnesium in the newborn
137. Magnesium intoxication in a premature infant
138. Neonatal magnesium disturbances
139. The action of adrenalin on the pregnant human uterus
140. A study of the adrenotropic receptors
141. Differentiation of receptors responsive to isoproterenol
142. Differentiation of receptor systems activated by sympathomimetic amines
143. Norepinephrine, epinephrine and the sympathomimetic amines
144. The role of cyclic AMP in the regulation of smooth muscle cell contraction in the uterus
145. Inter-relations between β-adrenergic receptors, adenylate cyclase and calcium
146. The uterine relaxant properties of isoxsuprine
147. Effect of certain smooth muscle depressants on isolated human myometrial tissue
148. Phenethanolamines and inhibition of human myometrium
149. Action of isoxsuprine and its (+) isomer on the pregnant human uterus
150. Isoxsuprine in premature labour
151. Arrest of premature labor by isoxsuprine
152. Arrest of premature labor
153. Fetal cardiac effects of maternal isoxsuprine infusion
154. The use of isoxsuprine for the arrest of premature labor
155. Inhibitory action of new sympathomimetic amine (DU-21220) on the nongravid uterus
156. Effect of ritodrine on human uterine motility and cardiovascular responses in term labor and the early postpartum state
157. Inhibition of human myometrial activity by a new β-adrenergic drug (DU-21220)
158. The relaxant action of ritodrine, a sympathomimetic amine, on the uterus during term labor
159. The effects of ritodrine hydrochloride on uterine activity and the cardiovascular system
160. Premature labour
161. A clinical trial with ritodrine in threatened premature labour
162. The treatment of premature labour with ritodrine hydrochloride
163. A multicentre trial with ritodrine in the treatment of premature labour in patients with intact membranes
164. Uterine and cardiovascular effects of ritodrine in premature labor
165. Effect of ritodrine infusion on uterine and umbilical blood flow in pregnant sheep
166. Relaxing effects of β-receptor stimulators in isolated gravid human myometrium
167. Effects of terbutaline on human myometrial activity and endometrial blood flow
168. Effects of terbutaline on human uterine motility at term
169. The relaxing effect of terbutaline on the human uterus during term labor
170. Terbutaline, un nuevo uteroinhibidor
171. Inhibition of premature labor by terbutaline
172. Effects of terbutaline on the pregnant baboon and fetus
173. Effect of terbutaline on cardiovascular state and uterine blood flow in pregnant ewes
174. Some metabolic and hormonal effects of salbutamol in man
175. Metabolic effects of salbutamol infusion during premature labour
176. Metabolic effects of oral salbutamol
177. 2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion
178. Effects of ritodrine hydrochloride on uterine activity and the cardiovascular system in toxemic patients
179. Insulin requirements in pregnant diabetics with premature labour controlled by ritodrine
180. The effect of oral ritodrine on maternal and fetal carbohydrate metabolism
181. Clinical evaluation of diazoxide
182. A review of its pharmacological properties and therapeutic use in hypertensive crisis
183. Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine
184. Studies on the mechanism of antihypertensive action of diazoxide: In vitro vascular pharmacodynamics
185. Influence of intravenous injection rate on protein binding and vascular activity of diazoxide
186. Diazoxide blood levels in man
187. Diazoxide and renal function in man
188. Studies of insulin secretion in the perfused rat pancreas
189. The relaxant effect of diazoxide on isolated gravid and nongravid human myometrium
190. The relaxant effect of diazoxide on nongravid human myometrium in vivo
191. The inhibitory effect of diazoxide in normal term labor
192. Diazoxide and the treatment of the acute hypertensive emergency in obstetrics
193. Effects of diazoxide in human labor and the fetus-neonate
194. Tocolytic properties of diazoxide
195. Effects of diazoxide and beta adrenergic drugs on spontaneous and induced uterine activity in the pregnant baboon
196. The inhibitory action of diazoxide on uterine activity in the subhuman primate: Placental transfer and effect on the fetus
197. Prolonged infusion of diazoxide in the management of premature labor in the baboon
198. The effect of diazoxide on uterine blood flow in pregnant sheep
199. The control of hypertension in labour
200. Effects of fetal exposure to diazoxide in man
201. Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy
202. Placental transfer of diazoxide and its hazardous effect on the newborn
203. Improvement in insulin secretion in diabetes after diazoxide
204. 2α in the control of the pregnant uterus
205. Electrophysiology of myometrium
206. Treatment of threatened premature labor with large doses of progesterone
207. Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor
208. Regulation of myometrial composition, growth and activity
209. Efficacy of 17α hydroxyprogesterone caproate in the prevention of premature labor
210. Effect of meperidine on uterine contractility during pregnancy and pre-labor
211. ++ antagonists and anti-inflammatory drugs
212. The applicability of labor inhibition to the problem of premature labor